Docket #: S05-206
Fluorescent Cell Barcoding (FCB) in Flow Cytometry to Enable High-Throughput Drug Screening and Large-Scale Signaling Profiling
Applications
- High-throughput screening in drug development
- Large-scale signaling profiling
Advantages
- Increased throughput, compared to current methods in flow cytometry, with an acquisition time of 5-15 minutes per 96-well plate
- Decreased cost in sample labeling with 100-fold reduced antibody consumption
Publications
- Krutzik PO and Nolan GP, "Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling." Nature Methods 3, 361 - 368 (2006)
Patents
- Published Application: 20080241820
- Published Application: 20110263457
- Issued: 8,003,312 (USA)
Similar Technologies
-
Biomarkers for Ovarian Cancer Diagnostics Prognostics as a Guide to Individualized Therapies S15-338Biomarkers for Ovarian Cancer Diagnostics Prognostics as a Guide to Individualized Therapies
-
Knowledge Base Coordinator S05-123Knowledge Base Coordinator
-
GateFinder: Automated Identification of Simple FACS Signatures from High Dimensional Mass Cytometry S15-051GateFinder: Automated Identification of Simple FACS Signatures from High Dimensional Mass Cytometry